• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
    • Fat Tail Daily
    • James Cooper’s Mining Memo
    • The Daily Reckoning Australia
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services
Latest ASX News

Bubs Australia [ASX:BUB] Shares Rise on ‘Material’ Guidance Upgrade

Like 0

By Kiryll Prakapenka, Friday, 17 June 2022

On Friday, Bubs Australia [ASX:BUB] has released a 'materially' updated guidance for FY22.

On Friday, Bubs Australia [ASX:BUB] has released a ‘materially’ updated guidance for FY22.

BUB shares were up 9% in late afternoon trade.

That means that the infant formula stock is now up 75% in the last month alone:

ASX:BAB stock prices chart

Source: TradingView.com

Bubs FY22 guidance ‘materially’ upgraded

Yesterday, we covered BUB’s supply agreement with Walmart. There we noted:

‘In the recent slew of supply updates, Bubs is yet to divulge any hard numbers.

‘What is the expected sales boost from these supply deals? And is it reasonable to assume US consumers and retailers will take a bigger liking to BUB products than before?

‘What happens when the local American brands return to full production capacity? Who will American consumers be loyal to then?’

Well, today, Bubs did give investors some hard numbers.

Bubs advised on Friday that there has been a ‘material upgrade’ to its FY22 revenue and earnings expectations.

Bubs now expects FY22 gross revenue to exceed $100 million.

BUB also expects a 100% increase on its 1H22 underlying EBITDA of $1.2 million.

The figures don’t include non-cash equity expenses, such as share payments and equity transactions.

In February, Bubs expected ‘modest Half on Half growth’ and was looking at $38.5 million in gross revenue.

BUB shares and the US baby formula horizon

The upgraded revenue outlook doesn’t only stem from the emergency US supply orders.

BUB also flagged ‘strong momentum in China’ as a source of boosted sales.

As Bubs CEO Kristy Carr commented:

‘Due to a strong momentum in China and the unanticipated volume of sales in the USA, complemented by Bubs’ demonstrated agility and speed to respond to the call for action with first mover advantage, Fourth Quarter turnover is likely to be higher than originally anticipated.

‘It has been an extraordinary journey for Bubs to have had over 12 months of in-market experience to provide the first response to USA’s infant formula shortage, which is likely to change the industry landscape in the USA. This has significantly accelerated our entry to one of the largest infant formula markets in the world, and we look forward to introducing more American families to Bubs’ full range of products.’

Now, in times of crisis, inflation, and rising interest rates, it can seem impossible to know what move to make next.

But Fat Tail’s veteran strategist Jim Rickards has been through many a time such as this.

Recently, Jim prepared an investment strategy for these troubled times.

To read more about his ideas for investing in these strange times, click here.

Regards,

Kiryll Prakapenka,
For Money Morning

 

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Kiryll Prakapenka

Kiryll’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • Two Races, One Tuesday
    By Dr. Lachlann Tierney

    Copper is a whisker off its record and uranium contracts just hit an all-time high. So why are ASX miners priced like rank outsiders heading into Tuesday’s big race?

  • Why Floor Prices Give Aussie Miners a Crucial Advantage
    By James Cooper

    Rare earths company Lynas announced stellar revenue numbers in last week’s quarterly results. And one detail behind the numbers stood out. Floor price agreements are becoming more common, driven by the US desire to increase non-China supply of key critical minerals.

  • AI Speaks DNA Now
    By Charlie Ormond

    Some of the most exciting work in AI looks nothing like ChatGPT. Let’s peek into the future with new AI paradigms, including some that only speak DNA and design novel viruses and drugs.

Primary Sidebar

Latest Articles

  • Two Races, One Tuesday
  • Why Floor Prices Give Aussie Miners a Crucial Advantage
  • AI Speaks DNA Now
  • Good Earnings Bad Reactions
  • Saving the West: A Marshall Plan for Minerals

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / AFSL: 323 988